Cancer Center

MCW Cancer Center Joins Elite Group of Top 30 Clinical Research Centers in the U.S.

Staying close to home for the best and newest cancer care possible is invaluable for patients, their families and our entire community. The Medical College of Wisconsin Cancer Center joins an elite group of the top 30 cancer centers in the United States, confirming that the very best cancer treatment is available right here in Milwaukee.

This distinction was recently announced with the award of a National Cancer Institute competitive grant, naming MCW a National Clinical Trials Network - Lead Academic Participating Site . The distinction of this selection is especially significant because of the rarity of cancer centers chosen that are not yet NCI designated. In fact, all other 30 centers currently part of the Lead Academic Participating Sites are NCI designated and there are 40 NCI designated cancer centers that do not have this distinction.

For this honor, the MCW Cancer Center met objective external measurements, including the strength and innovation of ongoing research and science, and confirmation of robust participation in National Clinical Trial Network and other cooperative group trials. The grant is awarded so an already outstanding and high potential clinical research enterprise can move to the next level of scientific engagement, research driven treatments and outstanding clinical care.

The MCW Cancer Center Clinical Trials Office was established in 2012 and since that time, the number of cancer clinical trials offered, and the number of patients participating in these trials, has more than doubled. It is the work of the CTO research professionals, and the clinical investigators they support, that made it possible to even consider applying for the grant.